Colloquium to Assess Ten Years of Chickenpox Vaccination

Sabin's picture Submitted by Sabin on

NEW YORK, November 4, 2005—Many of the world’s leading experts on the varicella-zoster virus (VZV)—which causes chickenpox (varicella), shingles (herpes zoster) and postherpetic neuralgia (PHN)—will convene in New York on November 7 to discuss global VZV issues, including: the impact of the vaccine in disease reduction; the FDA’s recent approval of MMRV; the effectiveness of an experimental shingles vaccine in reducing the incidence of shingles; and the poten

Sabin Receives $150,000 Grant to Strategize for Introduction and Sustainable Use of Vaccines in Developing Countries

Sabin's picture Submitted by Sabin on

WASHINGTON, D.C., Sept. 7, 2005 – The Albert B. Sabin Vaccine Institute (Sabin), a leader in promoting the development and use of safe and effective vaccines to prevent disease, announced receipt of a grant of $150,000 from the Bill & Melinda Gates Foundation for the sponsorship of a vaccine policy colloquium to be held at Cold Spring Harbor, Long Island, New York, October 19-21, 2005.

Pages